USD 0.02
(3.88%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 26.55 Thousand USD | 27.85% |
2022 | 20.76 Thousand USD | -72.87% |
2021 | 76.55 Thousand USD | 47.0% |
2020 | 52.07 Thousand USD | 217.98% |
2019 | 16.37 Thousand USD | -26.53% |
2018 | 22.29 Thousand USD | -85.8% |
2017 | 157.01 Thousand USD | 0.0% |
2015 | 173.4 Thousand USD | 95.59% |
2014 | 88.65 Thousand USD | 18578.63% |
2013 | 474.63 USD | 0.0% |
2009 | 102.11 Thousand USD | -45.79% |
2008 | 188.35 Thousand USD | -82.03% |
2007 | 1.04 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 2454.00 USD | -50.54% |
2024 Q1 | 4962.00 USD | -63.66% |
2023 Q2 | 3326.00 USD | 38.64% |
2023 Q1 | 2399.00 USD | -66.44% |
2023 Q4 | 13.65 Thousand USD | 185.93% |
2023 FY | 26.55 Thousand USD | 27.85% |
2023 Q3 | 4775.00 USD | 43.57% |
2022 FY | 20.76 Thousand USD | -72.87% |
2022 Q2 | 7857.00 USD | 70.25% |
2022 Q3 | 1148.00 USD | -85.39% |
2022 Q4 | 7148.00 USD | 522.65% |
2022 Q1 | 4615.00 USD | -21.27% |
2021 Q3 | 3484.00 USD | -26.98% |
2021 Q4 | 5862.00 USD | 68.25% |
2021 Q1 | 62.43 Thousand USD | 0.0% |
2021 FY | 76.55 Thousand USD | 47.0% |
2021 Q2 | 4771.00 USD | -92.36% |
2020 FY | 52.07 Thousand USD | 217.98% |
2019 FY | 16.37 Thousand USD | -26.53% |
2018 FY | 22.29 Thousand USD | -85.8% |
2017 FY | 157.01 Thousand USD | 0.0% |
2015 FY | 173.4 Thousand USD | 95.59% |
2014 Q2 | 59.53 USD | -9.82% |
2014 FY | 88.65 Thousand USD | 18578.63% |
2014 Q3 | 49.30 USD | -17.17% |
2014 Q1 | 66.01 USD | -69.62% |
2014 Q4 | 38.56 USD | -21.79% |
2013 Q3 | 76.55 USD | -21.76% |
2013 FY | 474.63 USD | 0.0% |
2013 Q4 | 217.28 USD | 183.84% |
2013 Q2 | 97.84 USD | 20.25% |
2013 Q1 | 81.37 USD | 0.0% |
2010 Q3 | 71.94 Thousand USD | -29.44% |
2010 Q1 | 98.23 Thousand USD | 23.97% |
2010 Q2 | 101.95 Thousand USD | 3.8% |
2009 FY | 102.11 Thousand USD | -45.79% |
2009 Q4 | 79.23 Thousand USD | 1124.08% |
2009 Q1 | 10.44 Thousand USD | 0.0% |
2009 Q3 | 6473.00 USD | 8.52% |
2009 Q2 | 5965.00 USD | -42.87% |
2008 FY | 188.35 Thousand USD | -82.03% |
2007 Q1 | 378.11 Thousand USD | 0.0% |
2007 Q2 | 391.08 Thousand USD | 3.43% |
2007 FY | 1.04 Million USD | 0.0% |
2006 Q2 | 468.4 Thousand USD | 37.22% |
2006 Q1 | 341.35 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
China Medicine Corporation | 6.71 Million USD | 99.605% |
DH Enchantment Inc. | 144.83 Thousand USD | 81.667% |
Exlites Holdings International, Inc. | 34.23 Thousand USD | 22.437% |
Itonis, Inc. | 40.11 Thousand USD | 33.809% |
MediPal Holdings Corporation | 1.22 Billion USD | 99.998% |
PD-Rx Pharmaceuticals, Inc. | 6.9 Million USD | 99.615% |
Pharmagen, Inc. | 6038.12 USD | -339.74% |
Suzuken Co., Ltd. | 993.51 Million USD | 99.997% |